Retinopathy News and Research

RSS

Innovative treatment improves vision of a patient suffering from melanoma-associated retinopathy

Innovative treatment has improved the vision of a patient suffering from a rare cancer-related syndrome affecting the eye, new research in the journal JAMA Ophthalmol reports.

30 Apr 2019

Study shows how AI can improve physicians' diagnostic accuracy

As artificial intelligence continues to evolve, diagnosing disease faster and potentially with greater accuracy than physicians, some have suggested that technology may soon replace tasks that physicians currently perform.

19 Mar 2019

Proteins linked with diabetic complications and heart disease in diabetic patients identified

Protein pathways that are closely linked to changes in both triglyceride and hemoglobin A1c levels in diabetic patients have been identified in new research by the Intermountain Medical Center Heart Institute in Salt Lake City.

13 Mar 2019

Laser-based technique allows doctors to image the whole eye in 3D

Scientists have developed a laser-based technique that can produce a full 3D image of all the layers of the retina, allowing doctors to better diagnose and treat eye diseases such as cataracts, diabetic retinopathy, and cancer.

6 Mar 2019

UVA expands telehealth capacity to better prevent or manage chronic conditions

The University of Virginia Health System is expanding its telehealth capacity to help patients across Virginia better prevent or manage chronic conditions that include diabetes, prediabetes and heart disease.

27 Feb 2019

NIH scientists zero in on genes associated with AMD

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration, a leading cause of vision loss and blindness among people age 65 and older.

12 Feb 2019

New target appears to aid recovery after optic nerve trauma

When a car crash or explosion results in an optic nerve injury, eliminating an enzyme known to promote inflammation appears to aid recovery, scientists report.

11 Feb 2019

Lab model reveals the formation of new blood vessels

To provide sufficient oxygen to tissues and organs within the body, blood vessels need to sprout new offshoots to form a widespread blood supply network, much like the trunk, branches, and twigs of a tree.

31 Jan 2019

Researchers use AI to diagnose diabetes-related eye disease

Researchers have used artificial intelligence to support the instant diagnosis of one of the top causes of blindness, diabetes-related eye disease, in its earliest stages.

8 Jan 2019

Russian scientists create hardware-information system for brain disorders treatment

A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.

13 Dec 2018

Novel approach could provide painless, efficient alternative for treating eye diseases

Nanyang Technological University, Singapore scientists have developed a 'contact lens' patch with microneedles that could provide a painless and efficient alternative to current methods of treating eye diseases such as glaucoma and macular degeneration.

19 Nov 2018

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

Researchers create new devices to mechanically stress retinal cells

Researchers at Utah State University have developed new devices to mechanically stress human cells in the lab.

25 Oct 2018

Immunotherapy medicine found to be effective in treating uveitis

A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.

19 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Premature babies with low levels of blood platelets have increased risk of blindness

Premature babies with low levels of platelets (thrombocytes) in their blood run a greatly increased risk of being afflicted with a severe variation of retinopathy of prematurity, an eye disease that can cause blindness, according to a study from Sweden and US published in the journal JCI Insight.

11 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.

1 Oct 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018